BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Xenetic Biosciences and PeriNess Announce First Patient Dosed in Investigator-Initiated Study at Tel Aviv Sourasky University Medical Center Evaluating Systemic DNase in Combination with CAR T Cells for Large B-Cell Lymphoma

  October 15, 2026

   · 

  9 min read
• Press Releases

  Caris Life Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026

  October 15, 2026

   · 

  1 min read
• Press Releases

  SimBioSys Secures FDA Clearance for TumorSight® Risk, Introducing the World’s First AI-Powered, MRI-Derived Breast Cancer Recurrence Risk Assessment

  October 15, 2026

   · 

  5 min read
• Press Releases

  Eisai Deepens Its Oncology Evidence Base at ESMO Congress 2026

  October 15, 2026

   · 

  29 min read
• Press Releases

  Sirona Medical Raises $40M Series D as Platform Usage Triples

  October 15, 2026

   · 

  4 min read
• Press Releases

  New composite outcomes data show patients treated with Lilly’s Omvoh (mirikizumab-mrkz) achieved comprehensive corticosteroid-free disease control in ulcerative colitis and corticosteroid-free deep remission in Crohn’s disease at one year

  October 15, 2026

   · 

  17 min read
• Press Releases

  HeartBeam Joins European EXIT-CVD Research Consortium to Advance At-Home ECG Monitoring for Early Detection of Acute Coronary Syndrome (ACS) in High-Risk Patients

  October 15, 2026

   · 

  9 min read
• 

  Neuroscience

  Arrowhead’s blood-brain barrier tech is ‘arguably better’ than others, analysts say after data drop

  Arrowhead Pharmaceuticals’ siRNA candidate achieved “compelling” tau reductions in an early study of healthy volunteers, with a magnitude of effect that seems to outperformother blood-brain barrier platforms, according to Stifel.

  October 15, 2026

   · 

  3 min read

   · 

  Tristan Manalac
• Press Releases

  Akari Therapeutics CEO Highlights Differentiated ADC Payload Strategy and Path Toward Clinical Development in New CEO Corner

  October 15, 2026

   · 

  8 min read
• Press Releases

  Edesa Biotech Announces FDA IND Clearance for Phase 2 Vitiligo Study

  October 15, 2026

   · 

  6 min read